Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis
- PMID: 762246
- PMCID: PMC371915
- DOI: 10.1172/JCI109275
Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis
Abstract
Cholic acid biosynthesis is defective in individuals with cerebrotendinous xanthomatosis (CTX) and is associated with the excretion of 5beta-cholestane-3alpha,7alpha, 12alpha,25-tetrol, an intermediate in the 25-hydroxylation pathway of cholic acid in CTX. To define the enzymatic defect in CTX, two suspected precursors of cholic acid, namely 5beta-[7beta-(3)H]cholestane-3alpha,7alpha, 12alpha-triol and 5beta-[24-(14)C]cholestane-3alpha,7alpha, 12alpha,24S,25-pentol were examined by both in vivo and in vitro experiments. A third precursor, 5beta-[7beta-(3)H]-cholestane-3alpha,7alpha, 12alpha,25-tetrol, was compared with them in vitro. In the in vivo experiments, each one of the labeled precursors was administered intravenously to two CTX and two control subjects. In the controls, 5beta-[7beta-(3)H]cholestane-3alpha,7alpha, 12alpha-triol as well as 5beta-[24-(14)C]-cholestane-3alpha,7alpha, 12alpha,24S,25-pentol were rapidly converted to labeled cholic acid. Maximum specific activity values were reached within 1 d after pulse labeling, followed by exponential decay of the cholic acid specific activity curves. In contrast, these two precursors differed widely when administered to two CTX patients. While 5beta-[24-(14)C]cholestane-3alpha,7alpha, 12alpha,24S,25-pentol was rapidly converted to [24-(14)C]cholic acid and yielded identical decay curves with those obtained in the control subjects, maximum specific activity values in [7beta-(3)H]cholic acid were much lower and peaked only on the second day after the injection of 5beta-[7beta-(3)H]cholestane-3alpha,7alpha, 12alpha-triol. Furthermore, an appreciable amount of (3)H label was present in the 5beta-cholestane-3alpha,7alpha, 12alpha,25-tetrol isolated from the bile of the subjects with CTX. In the in vitro experiments, three enzymes on the 25-hydroxylation pathway of cholic acid were examined in both control and CTX subjects. The rate of the 25-hydroxylation of 5beta-cholestane-3alpha,7alpha, 12alpha-triol in CTX patients was comparable to that in the controls. Similarly, the transformation of 5beta-cholestane-3alpha,7alpha, 12alpha,24S,25-pentol to cholic acid, catalyzed by soluble enzymes, proceeded at approximately equal rates in CTX and in control individuals. On the other hand, the rate of 5beta-cholestane-3alpha,7alpha, 12alpha,24S,25-pentol formation was about four times greater in the control subjects than in the CTX patients.The results of the in vivo as well as the in vitro experiments suggest that the site of the enzymatic defect in CTX is at the 24S-hydroxylation of 5beta-cholestane-3alpha,7alpha, 12alpha,25-tetrol. The relative deficiency of this hydroxylase in CTX patients, accompanied by the accumulation of its substrate in bile and feces, probably accounts for the subnormal production of bile acids in CTX patients.
Similar articles
-
Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.J Clin Invest. 1975 Jul;56(1):226-31. doi: 10.1172/JCI108071. J Clin Invest. 1975. PMID: 1141434 Free PMC article.
-
A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.J Clin Invest. 1976 Apr;57(4):897-903. doi: 10.1172/JCI108366. J Clin Invest. 1976. PMID: 181403 Free PMC article.
-
Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.J Biol Chem. 2001 Sep 14;276(37):34579-85. doi: 10.1074/jbc.M103025200. Epub 2001 Jul 13. J Biol Chem. 2001. PMID: 11454857
-
Inborn errors of bile acid metabolism.J Inherit Metab Dis. 1991;14(4):478-96. doi: 10.1007/BF01797919. J Inherit Metab Dis. 1991. PMID: 1749214 Review.
-
[Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders].Ryoikibetsu Shokogun Shirizu. 1995;(8):362-6. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8581653 Review. Japanese. No abstract available.
Cited by
-
A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.J Clin Invest. 1985 Feb;75(2):448-55. doi: 10.1172/JCI111719. J Clin Invest. 1985. PMID: 3919058 Free PMC article.
-
Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.J Clin Invest. 1980 Jun;65(6):1418-30. doi: 10.1172/JCI109806. J Clin Invest. 1980. PMID: 7410549 Free PMC article.
-
Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.J Inherit Metab Dis. 1988;11(1):56-75. doi: 10.1007/BF01800057. J Inherit Metab Dis. 1988. PMID: 3128689
-
Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study.J Clin Invest. 1983 Jan;71(1):142-8. doi: 10.1172/jci110742. J Clin Invest. 1983. PMID: 6848555 Free PMC article.
-
Anomalous enantioselectivity in the sharpless asymmetric dihydroxylation reaction of 24-nor-5beta-cholest-23-ene-3alpha,7alpha,12alpha-triol: synthesis of substrates for studies of cholesterol side-chain oxidation.Lipids. 1999 Apr;34(4):395-405. doi: 10.1007/s11745-999-0378-4. Lipids. 1999. PMID: 10443973
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources